Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Ending Cash Position : ¥522 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Ending Cash Position?

Hubei Hongyuan Pharmaceutical Technology Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥522 Mil.

Hubei Hongyuan Pharmaceutical Technology Co's quarterly Ending Cash Position declined from Sep. 2023 (¥823 Mil) to Dec. 2023 (¥356 Mil) but then increased from Dec. 2023 (¥356 Mil) to Mar. 2024 (¥522 Mil).

Hubei Hongyuan Pharmaceutical Technology Co's annual Ending Cash Position increased from Dec. 2021 (¥96 Mil) to Dec. 2022 (¥237 Mil) and increased from Dec. 2022 (¥237 Mil) to Dec. 2023 (¥356 Mil).

Hubei Hongyuan Pharmaceutical Technology Co Ending Cash Position Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Ending Cash Position Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

144.44

224.27

95.78

236.72

356.40

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
	Jun15	Dec15	Jun16	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															2,328.23	193.28	822.86	356.40	521.97

Hubei Hongyuan Pharmaceutical Technology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hubei Hongyuan Pharmaceutical Technology Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	236.72	+	119.684
	=	356

Hubei Hongyuan Pharmaceutical Technology Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	356.405	+	165.567
	=	522

Hubei Hongyuan Pharmaceutical Technology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600

Website

http://www.hbhypharm.com

Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines